Product Information
ZOLMITRIPTAN 5 MG NASAL SPRAY is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $41.2920 per EA under NDC 45802071191. Its NADAC has been published 241 times since Jan 12, 2022.
FDA first approved this application on Sep 30, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the zolmitriptan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802071191
Classification
Generic
Dosage Form
SPRAY
Route
NASAL
Effective Date
8/19/2026
Active Ingredients
ZOLMITRIPTANApproval Type
Generic (ANDA)
FDA Application
ANDA212469FDA Approved
9/30/2021
TE Code
AB
On Market Since
11/16/2021
Pharmacological Classes
Price Statistics
The NADAC for ZOLMITRIPTAN 5 MG NASAL SPRAY has been published 241 times since Jan 12, 2022, and over the history we have for it it has declined 46.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $41.2920 per EA |
|---|---|
| All-time high | $80.8103 (Nov 16, 2022) |
| All-time low | $38.6728 (Nov 19, 2025) |
| 52-week high | $47.6290 |
| 52-week low | $38.6728 |
| Median price | $62.7833 |
| Average price | $61.0783 |
| Largest weekly change | -33.7% (Apr 17, 2024) |
| Weeks tracked | 241 |
| Tracking since | Jan 12, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the zolmitriptan market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZOLMITRIPTAN 5 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 5 MG NASAL SPRAY, manufactured by Padagis Israel Pharmaceuticals Ltd, is $41.2920 per EA (NDC 45802071191), effective Aug 19, 2026.
How has the price of ZOLMITRIPTAN 5 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for ZOLMITRIPTAN 5 MG NASAL SPRAY has declined 46.6%. It has been tracked across 241 weekly CMS publications since Jan 12, 2022.
What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 5 MG NASAL SPRAY?
Since Jan 12, 2022, the NADAC for ZOLMITRIPTAN 5 MG NASAL SPRAY has ranged from a low of $38.6728 (Nov 19, 2025) to a high of $80.8103 (Nov 16, 2022), with a median of $62.7833 per EA.
Are there cheaper alternatives to ZOLMITRIPTAN 5 MG NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of ZOLMITRIPTAN 5 MG NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZOLMITRIPTAN 5 MG NASAL SPRAY?
ZOLMITRIPTAN 5 MG NASAL SPRAY (NDC 45802071191) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.